Results 211 to 220 of about 256,609 (339)

The Mechanisms and Pathophysiology of Mitral Regurgitation: A Narrative Review. [PDF]

Ann Card Anaesth
Neema PK, Panidapu N.
europepmc   +1 more source

Assessment of prognostic factors in patients undergoing surgery for non-rheumatic mitral regurgitation.

, 1980
S Saltissi, Alex Crowther, Christina Byrne, D J Coltart, B S Jenkins, M M Webb-Peploe   +5 more
openalex   +1 more source

Accessory mitral valve leaflet causing aortic regurgitation and left ventricular outflow tract obstruction. Case report and review of published reports. [PDF]

, 1988
J Sono, Roxane McKay, R Arnold
openalex   +1 more source

Perventricular Device Closure of Native Congenital Muscular Ventricular Septal Defects in Small Infants    ≤ 5 kg: Single‐Center Study of the Risk Factors for Failure of the Intervention and Non‐Optimal Outcome

Catheterization and Cardiovascular Interventions, Volume 106, Issue 4, Page 2160-2173, October 1, 2025.
ABSTRACT Background and Aims Perventricular device closure of muscular VSD in small infants is a less invasive option than surgical closure under cardiopulmonary bypass and offers better outcomes than palliative pulmonary artery banding. However, the specific risk factors that could affect procedural success and optimal outcomes have not been ...
Emine Hekim Yilmaz, Ilker Kemal Yucel, Murat Surucu, Huseyin Karadag, Ibrahim Halil Demir, Murat Cicek, Numan Ali Aydemir, Ahmet Celebi   +7 more
wiley   +1 more source

Acute Mitral Regurgitation Following Minimally Invasive Aortic Valve Replacement. [PDF]

Ann Card Anaesth
Singh A, Anthappan SR, Preeti P, Mehta Y.   +3 more
europepmc   +1 more source

Feasibility and Safety of Transfemoral Aortic Valve Replacement Using Local Anesthesia in the Catheterization Suite Versus General Anesthesia in the Operation Theater

Catheterization and Cardiovascular Interventions, Volume 106, Issue 4, Page 2454-2468, October 1, 2025.
ABSTRACT Background For over a decade, transfemoral transcatheter aortic valve replacements (TF‐TAVR) have been performed at the University Hospital of Nancy. A minimalistic approach to TF‐TAVR, conducted without general anesthesia and entirely percutaneously in a catheterization suite (simplified approach), has been reported to be as safe and ...
Guillaume Abadié, Pierre Adrien Metzdorf, Giuseppe Lauria, Jeanne Varlot, Mazen Elfarra, Florian Eggenspieler, Juan‐Pablo Maureira, Batric Popovic, Edoardo Camenzind   +8 more
wiley   +1 more source

WATCHMAN Gone Astray, Catastrophic Mitral Regurgitation Following Device Dislodgement. [PDF]

Ann Card Anaesth
Jouryyeh B, Beshara M.
europepmc   +1 more source

Presystolic mitral closure sound in aortic regurgitation with left ventricular hypertrophy and first degree heart block.

, 1982
Thomas A. Traill, Nicholas J. Fortuin
openalex   +1 more source

Mitral Regurgitation in Ventricular Premature Contractions [PDF]

, 1981
Edward L. Yellin, Robert W.M. Frater
openalex   +1 more source

Two‐Year Results of Percutaneous Endocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy

Catheterization and Cardiovascular Interventions, Volume 106, Issue 4, Page 2763-2769, October 1, 2025.
ABSTRACT Background Hypertrophic obstructive cardiomyopathy (HOCM) is a hereditary myocardial disease. Percutaneous endocardial septal radiofrequency ablation (PESA) is an innovative approach for treating HOCM. Consequently, we present the outcomes of the PESA for HOCM. Methods This study included 20 patients with HOCM who received PESA.
NingNing Zheng, YiYuan Chen, YongBing Fu, Feng Xue, FangFang Zhang, Lin Ling, TingBo Jiang   +6 more
wiley   +1 more source